Follow-The-Filings

Security

CNTX

Context Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

6 owners max 0.0% (Marshall Wace - Marshall ...)

grid → activity →
owners 6
max % 0.0%
tracked value $18M
qoq A 4 R 2

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 2,948,441 $8M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 3,785,909 $6M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 1,424,374 $4M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 182,999 $479 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 140,017 $367 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Add 0.00 pp 57,231 $150 hist

6 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — —
Gross profit — — —
Gross margin — — —
Net income -$23.96M -$26.73M -$36.12M
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.05M $97.9M $68.35M
Total non-current assets * $15,524 $230,775 $140,066
Total assets $16.06M $98.13M $68.49M
Total current liabilities $4.19M $2.75M $8.02M
Total non-current liabilities * $0.00 $112,064 $0.00
Total equity $11.87M $95.27M $60.47M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$21.05M -$14.56M -$26.39M
Cash from investing $0.00 -$14.76M -$2.03M
Cash from financing $0.00 $109.29M -$15,268
Net change in cash -$21.05M $79.98M -$28.43M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders